News for The United Laboratories International Holdings Limited (3933.HK)

Published at

Mar 24, 2025 12:34 PM

by manilatimes.net

positive

positive

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist

NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF 3933.HK 0TDD.L

Read more →
Published at

Mar 24, 2025 11:20 AM

by manilatimes.net

positive

positive

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist

**media[574447]**

NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF 3933.HK 0TDD.L

Read more →